Dr. Oz jumps in as drug exec collapses during Oval Office press conference

Dr. Oz Assists as Drug Executive Collapses During Oval Office Event

A press conference in the Oval Office was unexpectedly interrupted on Thursday when a pharmaceutical executive fainted while President Donald Trump was announcing a new agreement aimed at lowering drug prices.

Incident in the Oval Office

The event focused on a deal between the administration and major drugmakers Eli Lilly and Novo Nordisk to expand access and reduce the cost of obesity medications, including Zepbound and Wegovy. During the remarks, David Ricks, CEO of Eli Lilly, paused and looked toward his right as one of the attendees collapsed.

“Are you okay? Gordon, are you okay?” — David Ricks, Eli Lilly CEO

The man was later identified as Gordon Findlay, global brand director at Novo Nordisk. As Findlay fell to his knees, Dr. Mehmet Oz, Administrator for the Centers for Medicare & Medicaid Services, quickly stepped in to assist him while President Trump observed the situation.

Response and Aftermath

Reporters were promptly escorted out of the room, and the press conference was temporarily paused. The Secretary of Health and Human Services was also present during the incident. Approximately thirty minutes later, the event resumed, and President Trump provided an update on the executive’s condition.

Presidential Update

President Trump later informed the press that Gordon Findlay was stable and receiving care following the episode.

The occurrence underscored the tense and unpredictable moments that can unfold during high-profile announcements within the White House.

Author’s Summary

During a White House briefing on lowering drug costs, Dr. Mehmet Oz aided Novo Nordisk’s Gordon Findlay after he collapsed, prompting a brief suspension of the event.

more

FOX 4 News Dallas-Fort Worth FOX 4 News Dallas-Fort Worth — 2025-11-06

More News